Copyright © 2005, The European Society of Cardiology
Tissue Doppler imaging does not show infraclinical alteration of myocardial function after contrast echocardiography
Cardiology Department, Academisch Ziekenhuis - VUB, 101 Laarbeeklaan, 1090 Brussels, Belgium
Received 20 December 2004; received in revised form 14 February 2005; accepted after revision 6 March 2005.
* Corresponding author. Tel.: +32 24776010; fax: +32 24532294. E-mail: bcosyns@skynet.be
| Abstract |
|---|
Background It has been previously suggested that simultaneous exposure of hearts to contrast and ultrasound can damage the myocardium and produce a transient decrease of the contractility in animals. Tissue Doppler imaging (TDI) is a useful tool to quantify the myocardial function with very high temporal resolution.
Aim of the study The aim of the study was to test whether contrast echocardiography (CE) can cause alteration of the myocardial function by using tissue Doppler analysis.
Methods Twenty-eight healthy patients (mean age: 44±22) underwent baseline echocardiography before and after 5min of continuous intravenous infusion of Sonovue from the apical views, using an intermediate mechanical index (MI=1). High frame rate images were acquired in tissue Doppler mode. Data were averaged over 3 cardiac cycles and analysed offline before and after CE.
Results There were no significant changes, before and after CE, in the peak systolic velocity (basal septum (BS): 6.2±2.2 vs 6.4±2.6; basal lateral (BL): 6.2±3.1 vs 6.4±3.3cm/s), in the peak diastolic E velocity (BS: 5.4±1.8 vs 5.3±1.7; BL: 7.3±2.4 vs 7.7±3.2cm/s), in the peak diastolic A velocity (BS: 6.3±1.9 vs 6.9±2.4; BL: 6.1±3.5 vs 6.2±2.5cm/s), in the peak systolic strain (BS: 16±7 vs 17±7; BL: 12.6±5 vs 12.9±5%) and in peak systolic strain rate (BS: 1.3±0.6 vs 1.4±0.6; BL: 1.2±0.5 vs 1.21±0.51 1/sec).
Conclusions Our data suggest that CE does not cause alterations in the myocardial function as assessed by tissue Doppler imaging. CE, even with high MI settings, usually used for left ventricular opacification, can be safely performed.
Keywords: Contrast echocardiography; Tissue Doppler imaging; Toxicity
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in Eur J Echocardiogr:
- Safety: The heart of the matter
- Sajad A. Hayat and Roxy Senior
Eur J Echocardiogr 2005 6: 235-237.[Abstract] [FREE Full Text]
This article has been cited by other articles:
![]() |
D. Vancraeynest, J. Kefer, C. Hanet, C. Fillee, C. Beauloye, A. Pasquet, B. L. Gerber, M. Philippe, and J.-L. J. Vanoverschelde Release of cardiac bio-markers during high mechanical index contrast-enhanced echocardiography in humans Eur. Heart J., May 2, 2007; 28(10): 1236 - 1241. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Van Camp, S. Droogmans, and B. Cosyns Bio-effects of ultrasound contrast agents in daily clinical practice: fact or fiction? Eur. Heart J., May 2, 2007; 28(10): 1190 - 1192. [Full Text] [PDF] |
||||
